ArticleBMC geriatrics2025
Validity and reliability of the Persian version of the SARC-F questionnaire among Iranian older adults.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia is recognized as a geriatric condition marked by a progressive decline in muscle mass and function. The SARC-F questionnaire was developed as a brief, self-reported, and cost-effective tool for screening sarcopenia. This study aims to translate and culturally adapt the SARC-F questionnaire into Persian and evaluate its psychometric properties for older adults attending outpatient geriatric clinics.
methodsThe study was conducted in two phases: translation and cultural adaptation, followed by psychometric evaluation. The Persian SARC-F was translated using the WHO forward-backward protocol and assessed for content validity using the Lawshe method. A cross-sectional study was conducted with 200 older adults aged 65 and above attending outpatient geriatric clinics in Tehran. Concurrent validity was assessed through a comparison of the Persian SARC-F with AWGS 2019 criteria for possible sarcopenia. Construct validity was assessed using the LEIPAD questionnaire, anticipating strong correlations with similar domains and weaker correlations with different domains. Internal consistency was determined using Cronbach's alpha, and test-retest reliability was evaluated using the intraclass correlation coefficient (ICC). The diagnostic characteristics were determined by constructing a receiver operating characteristic (ROC) curve using the AWGS 2019 criteria for possible sarcopenia.
resultsThe Persian SARC-F showed adequate content validity with S-CVI/Ave values of 0.97 for relevancy and clarity and 1 for simplicity. The CVR values for individual items ranged from 0.80 to 1. Concurrent validity was demonstrated with Spearman's correlations of (r = -0.73) for hand grip strength and (r = -0.76) for gait speed. Construct validity was supported by convergent and divergent validity. The Cronbach's alpha was 0.79, indicating good internal consistency. The ICC was 0.99, showing excellent test-retest reliability. The area under the curve (AUC) was 0.91 (95%CI: 0.86-0.95). Sensitivity, specificity, PPV, and NPV for the optimal cut point (≥ 4) were 84.9%, 96.5%, 96.9%, and 83.1%, respectively.
conclusionsThe Persian version of the SARC-F questionnaire is a valid and reliable tool with high diagnostic accuracy. It can be used for screening sarcopenia in Persian-speaking community-dwelling older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.